Alector - ALEC Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ALEC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALEC, but not buy additional shares or sell existing shares.
View ALEC analyst ratings or view top-rated stocks.

7 brokers have issued twelve-month price objectives for Alector's stock. Their ALEC share price forecasts range from $6.00 to $41.00. On average, they predict the company's share price to reach $16.75 in the next year. This suggests a possible upside of 79.0% from the stock's current price.
View analysts price targets for ALEC or view top-rated stocks among Wall Street analysts.

Alector's stock was trading at $9.23 on January 1st, 2023. Since then, ALEC stock has increased by 1.4% and is now trading at $9.36.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our ALEC earnings forecast.

Alector, Inc. (NASDAQ:ALEC) announced its quarterly earnings data on Thursday, November, 4th. The company reported $1.49 earnings per share for the quarter, topping the consensus estimate of ($0.46) by $1.95. The business earned $182.41 million during the quarter, compared to the consensus estimate of $407.41 million. Alector had a negative trailing twelve-month return on equity of 49.19% and a negative net margin of 102.49%.

4 employees have rated Alector Chief Executive Officer Arnon Rosenthal on Glassdoor.com. Arnon Rosenthal has an approval rating of 100% among the company's employees. This puts Arnon Rosenthal in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Kaleido Biosciences (KLDO), QUALCOMM (QCOM), Intel (INTC), Micron Technology (MU) and Cisco Systems (CSCO).

(ALEC) raised $177 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Alector's stock is owned by many different retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (0.47%), Los Angeles Capital Management LLC (0.30%), Nordea Investment Management AB (0.21%), UBS Group AG (0.20%), Swiss National Bank (0.16%) and Russell Investments Group Ltd. (0.14%). Insiders that own company stock include Arnon Rosenthal, Calvin Yu, Orbimed Advisors Llc, Richard H Scheller, Robert King, Robert Paul, Shehnaaz Suliman and Terrance Mcguire.
View institutional ownership trends.

Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALEC stock can currently be purchased for approximately $9.36.

Alector (NASDAQ:ALEC) has a market capitalization of $774.07 million and generates $207.09 million in revenue each year. The company earns $-36,330,000.00 in net income (profit) each year or ($1.66) on an earnings per share basis.

The company employs 208 workers across the globe.

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.alector.com. The company can be reached via phone at (415) 231-5660 or via email at ir@alector.com.